首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation
【24h】

Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation

机译:COPD,哮喘-COPD重叠综合征和气流受限哮喘患者肺功能的比较

获取原文
       

摘要

Background: This study was conducted in order to investigate the differences in the respiratory physiology of patients with chronic obstructive pulmonary disease (COPD), asthma-COPD overlap syndrome (ACOS), and asthma with airflow limitation (asthma FL+). Methods: The medical records for a series of all stable patients with persistent airflow limitation due to COPD, ACOS, or asthma were retrospectively reviewed and divided into the COPD group (n=118), the ACOS group (n=32), and the asthma FL+ group (n=27). All the patients underwent chest high-resolution computed tomography (HRCT) and pulmonary function tests, including respiratory impedance. Results: The low attenuation area score on chest HRCT was significantly higher in the COPD group than in the ACOS group (9.52±0.76 vs 5.09±1.16, P + group than in the COPD group (55.6% vs 25.0%, P 1) and peak expiratory flow rate were significantly higher in the asthma FL+ group than in the ACOS group (76.28%±2.54% predicted vs 63.43%±3.22% predicted, P + group than in the COPD group (112.05%±4.34% predicted vs 137.38%±3.43% predicted, P 1 in response to short-acting ?2-agonists was significantly greater in the ACOS group than in the COPD group (229±29?mL vs 72±10?mL, P + group (229±29?mL vs 153±21?mL, P + group than in the COPD group at the whole-breath (4.29±0.30?cmH2O/L/s vs 3.41±0.14?cmH2O/L/s, P 2O/L/s vs 2.68±0.10?cmH2O/L/s, P +, they may have distinct characteristics of the respiratory physiology and different responsiveness to bronchodilators.
机译:背景:本研究旨在调查慢性阻塞性肺疾病(COPD),哮喘-COPD重叠综合征(ACOS)和气流受限(哮喘FL + )。方法:回顾性分析一系列因COPD,ACOS或哮喘引起的持续性气流受限的稳定患者的病历,将其分为COPD组(n = 118),ACOS组(n = 32)和对照组。哮喘FL + 组(n = 27)。所有患者均接受了胸部高分辨率计算机断层扫描(HRCT)和肺功能检查,包括呼吸阻抗。结果:COPD组胸部HRCT的低衰减区域评分明显高于ACOS组(9.52±0.76 vs 5.09±1.16,P + 组)高于COPD组(55.6%vs 25.0%,哮喘FL + 组的P 1 )和呼气峰值峰值明显高于ACOS组(预测的76.28%±2.54%与预测的63.43%±3.22%,P + 组比COPD组(预测的112.05%±4.34%与预测的137.38%±3.43%)相比,P 1 对短效α 2 激动剂的反应显着ACOS组比COPD组更大(229±29?mL vs 72±10?mL,P + 组(229±29?mL vs 153±21?mL,P + 组在整个呼吸期间比COPD组要高(4.29±0.30?cmH 2 O / L / s与3.41±0.14?cmH 2 O / L / s,P 2 O / L / s和2.68±0.10?cmH 2 O / L / s,P + ,它们可能具有独特的呼吸生理特征和不同的反应性支气管扩张药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号